Literature DB >> 3518483

Biphasic concentration dependency of stimulation of myoblast differentiation by somatomedins.

J R Florini, D Z Ewton, S L Falen, J J Van Wyk.   

Abstract

It is widely believed that mitogens inhibit in vitro differentiation of myoblasts to form postmitotic myotubes, but we and others have shown that the mitogenic hormones insulin and the insulin-like growth factors (IGFs) stimulate myoblast differentiation. We now report the results of concentration-dependency studies that resolve this disagreement. We found that the IGFs give a biphasic dose-response curve; at low concentrations, there is progressive stimulation of L6 myoblast differentiation; at higher concentrations, there is a progressive decrease. Similar results were obtained with IGF-II and insulin. When differentiation was maximally stimulated (by 1,280 ng/ml insulin), adding rat IGF-II gave decreases in differentiation similar to those reported for other mitogens. Two trivial explanations have been eliminated: stimulation of differentiation (at low concentrations) is not due to enhanced survival or growth of the cells, and inhibition (at higher concentrations) is not a toxic effect. In L6 cells, epidermal growth factor and fibroblast growth factor had no effect on proliferation or differentiation. We conclude that the effects of medium components on myoblast differentiation cannot be generalized to indicate inhibition by all mitogens; depending on the cell lines and concentrations used, certain mitogens may either stimulate or inhibit differentiation.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3518483     DOI: 10.1152/ajpcell.1986.250.5.C771

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  22 in total

Review 1.  Exercise-induced hormonal changes and their effects upon skeletal muscle tissue.

Authors:  M R Deschenes; W J Kraemer; C M Maresh; J F Crivello
Journal:  Sports Med       Date:  1991-08       Impact factor: 11.136

2.  LONG R3IGF-I as a more potent alternative to insulin in serum-free culture of HEK293 cells.

Authors:  Danny Voorhamme; Catherine A Yandell
Journal:  Mol Biotechnol       Date:  2006-10       Impact factor: 2.695

Review 3.  Somatomedins: chemical and functional characteristics of the different molecular forms.

Authors:  A Barreca; F Minuto
Journal:  J Endocrinol Invest       Date:  1989-04       Impact factor: 4.256

4.  Maturation of the myogenic program is induced by postmitotic expression of insulin-like growth factor I.

Authors:  A Musarò; N Rosenthal
Journal:  Mol Cell Biol       Date:  1999-04       Impact factor: 4.272

5.  Effects of the sustained release of IGF-1 on extraocular muscle of the infant non-human primate: adaptations at the effector organ level.

Authors:  Christy L Willoughby; Stephen P Christiansen; Michael J Mustari; Linda K McLoon
Journal:  Invest Ophthalmol Vis Sci       Date:  2012-01-05       Impact factor: 4.799

Review 6.  Biological approaches to improve skeletal muscle healing after injury and disease.

Authors:  Burhan Gharaibeh; Yuri Chun-Lansinger; Tanya Hagen; Sheila Jean McNeill Ingham; Vonda Wright; Freddie Fu; Johnny Huard
Journal:  Birth Defects Res C Embryo Today       Date:  2012-03

7.  Role of insulin-like growth factors and myogenin in the altered program of proliferation and differentiation in the NFB4 mutant muscle cell line.

Authors:  D D Sarbassov; R Stefanova; V G Grigoriev; C A Peterson
Journal:  Proc Natl Acad Sci U S A       Date:  1995-11-21       Impact factor: 11.205

8.  Regulation of protein synthesis and degradation in L8 myotubes. Effects of serum, insulin and insulin-like growth factors.

Authors:  E A Gulve; J F Dice
Journal:  Biochem J       Date:  1989-06-01       Impact factor: 3.857

9.  A reappraisal of the role of insulin-like growth factor I in the regulation of human hematopoiesis.

Authors:  M Z Ratajczak; W I Kuczynski; K Onodera; J Moore; J Ratajczak; D A Kregenow; K DeRiel; A M Gewirtz
Journal:  J Clin Invest       Date:  1994-07       Impact factor: 14.808

Review 10.  Sarcopenia: etiology, clinical consequences, intervention, and assessment.

Authors:  T Lang; T Streeper; P Cawthon; K Baldwin; D R Taaffe; T B Harris
Journal:  Osteoporos Int       Date:  2009-09-25       Impact factor: 4.507

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.